Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA (XRAY)
:XRAY
XRAY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$12.16 - $31.00
Previous CloseN/A
Volume461.38K
Average Volume (3M)3.43M
Market Cap
$2.56B
Enterprise Value$5.77B
Total Cash (Recent Filing)$405.02M
Total Debt (Recent Filing)$476.51M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
May 08, 2025EPS Estimate
0.3Last Dividend Ex-Date
Mar 28, 2025Dividend Yield4.99%
Share Statistics
EPS (TTM)-4.55
Shares Outstanding199,293,380
10 Day Avg. Volume3,718,261
30 Day Avg. Volume3,426,697
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.82
Price to Cash Flow (P/CF)8.90
P/FCF Ratio8.90
Enterprise Value/Market Cap2.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.95
Enterprise Value/Ebitda-9.84
Forecast
1Y Price Target
$18.81Price Target Upside46.61% Upside
Rating ConsensusHold
Number of Analyst Covering15
---
Bulls Say, Bears Say
Bulls Say
Market PerformanceRevenue growth has been achieved in the German market for two consecutive quarters, despite previous challenges.
Product LaunchesThe company is expecting 20+ new product launches in 2025 and 2026, with recent launches like Orthophos SL in the Imaging segment showing successful results.
Bears Say
Earnings Performance4Q EPS of $0.26 comes in well below Street consensus of $0.43 and analyst's $0.42 estimate on revenue of $905 mln, which is an 11% decrease year over year.
Financial GuidanceInitial 2025 revenue guidance of $3,500-3,600 shows a 2 to 4% organic decline, which is well below the Street's view of $3,851 mln and analyst's view of $3,920 mln.
Market ChallengesThe magnitude of the challenges, both for 4Q'24 and FY25 guidance, were worse across the board, affecting parts such as Implants and Imaging.
---
Ownership Overview
0.54% Insiders
37.40% Mutual Funds
0.09% Other Institutional Investors
41.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XRAY FAQ
What was DENTSPLY SIRONA’s price range in the past 12 months?
DENTSPLY SIRONA lowest stock price was $12.16 and its highest was $31.00 in the past 12 months.
What is DENTSPLY SIRONA’s market cap?
DENTSPLY SIRONA’s market cap is $2.56B.
When is DENTSPLY SIRONA’s upcoming earnings report date?
DENTSPLY SIRONA’s upcoming earnings report date is May 08, 2025 which is in 18 days.
How were DENTSPLY SIRONA’s earnings last quarter?
DENTSPLY SIRONA released its earnings results on Feb 27, 2025. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.427 by -$0.167.
Is DENTSPLY SIRONA overvalued?
According to Wall Street analysts DENTSPLY SIRONA’s price is currently Undervalued.
Does DENTSPLY SIRONA pay dividends?
DENTSPLY SIRONA pays a Quarterly dividend of $0.636 which represents an annual dividend yield of 4.99%. See more information on DENTSPLY SIRONA dividends here
What is DENTSPLY SIRONA’s EPS estimate?
DENTSPLY SIRONA’s EPS estimate is 0.3.
How many shares outstanding does DENTSPLY SIRONA have?
DENTSPLY SIRONA has 199,293,380 shares outstanding.
What happened to DENTSPLY SIRONA’s price movement after its last earnings report?
DENTSPLY SIRONA reported an EPS of $0.26 in its last earnings report, missing expectations of $0.427. Following the earnings report the stock price went down -8.861%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA?
Currently, no hedge funds are holding shares in XRAY
---
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$18.81 (46.61% Upside)
$18.81 (46.61% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 698.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $250.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.1%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.40%
12-Months-Change
Fundamentals
Return on Equity
-34.77%
Trailing 12-Months
Asset Growth
-21.94%
Trailing 12-Months
Company Description
DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
---
XRAY Company Deck
---
XRAY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call outlined several areas of growth and strategic progress, particularly in Europe and the imaging segment. However, these were overshadowed by significant challenges in the Byte segment, U.S. sales decline, and macroeconomic pressures resulting in impairments and a cautious outlook for 2025.Read More>---
XRAY Net sales Breakdown
38.33% Essential Dental Solutions
28.00% Connected Technology Solutions
25.65% Orthodontic and Implant Solutions
8.01% Wellspect Healthcare
---
XRAY Stock 12 Month Forecast
Average Price Target
$18.81
▲(46.61% Upside)
Technical Analysis
Align Tech
―
Baxter International
―
Henry Schein
―
Patterson Companies
―
Zimmer Biomet Holdings
―
Best Analysts Covering XRAY
1 Year
1 Year Success Rate
4/34 ratings generated profit
1 Year Average Return
-25.38%
reiterated a buy rating 2 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -25.38% per trade.
---